These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19395075)

  • 1. Adolescents and asthma: why bother with our meds?
    Naimi DR; Freedman TG; Ginsburg KR; Bogen D; Rand CS; Apter AJ
    J Allergy Clin Immunol; 2009 Jun; 123(6):1335-41. PubMed ID: 19395075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to asthma controller medication regimens.
    Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
    Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare.
    Nguyen WT; Stewart C; Fisher K; Tolley E; Lew DB; Self TH
    Allergy Asthma Proc; 2005; 26(2):129-34. PubMed ID: 15971472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmeterol and Fluticasone Propionate in Children with Asthma.
    Nieto A; Mazón Á; Nieto M
    N Engl J Med; 2016 Dec; 375(22):e46. PubMed ID: 27959747
    [No Abstract]   [Full Text] [Related]  

  • 7. Salmeterol and Fluticasone Propionate in Children with Asthma.
    Stempel DA; Szefler SJ; Pascoe SJ
    N Engl J Med; 2016 Dec; 375(22):e46. PubMed ID: 27959746
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
    Aalbers R
    Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma.
    Mendes ES; Rebolledo P; Wanner A
    Chest; 2012 May; 141(5):1184-1189. PubMed ID: 21980058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.
    Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Stanford R; Su Z; Sampalis JS
    Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving pediatric asthma patient outcomes by incorporation of effective interventions.
    Marosi A; Stiesmeyer J
    J Asthma; 2001 Dec; 38(8):681-90. PubMed ID: 11758897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma.
    Markham A; Adkins JC
    Pharmacoeconomics; 2000 Dec; 18(6):591-608. PubMed ID: 11227397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis.
    Balkrishnan R; Nelsen LM; Kulkarni AS; Pleasants RA; Whitmire JT; Schechter MS
    J Asthma; 2005 Feb; 42(1):35-40. PubMed ID: 15801326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor disease control among insured users of high-dose combination therapy for asthma.
    Broder MS; Chang EY; Kamath T; Sapra S
    Allergy Asthma Proc; 2010; 31(1):60-7. PubMed ID: 20167146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
    Condemi JJ; Goldstein S; Kalberg C; Yancey S; Emmett A; Rickard K
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):383-9. PubMed ID: 10227337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.